|
SFRS9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.286000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.359000E-01 |
| Normal-vs-Stage2 |
4.588200E-01 |
| Normal-vs-Stage3 |
4.117600E-01 |
| Normal-vs-Stage4 |
4.950200E-01 |
| Stage1-vs-Stage2 |
7.595200E-01 |
| Stage1-vs-Stage3 |
1.952960E-01 |
| Stage1-vs-Stage4 |
3.477400E-01 |
| Stage2-vs-Stage3 |
2.203800E-01 |
| Stage2-vs-Stage4 |
2.949000E-01 |
| Stage3-vs-Stage4 |
9.267400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.272400E-01 |
| Normal-vs-AfricanAmerican |
3.476800E-01 |
| Normal-vs-Asian |
9.395400E-01 |
| Caucasian-vs-AfricanAmerican |
1.583960E-01 |
| Caucasian-vs-Asian |
8.297600E-01 |
| AfricanAmerican-vs-Asian |
7.819000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.039000E-01 |
| Normal-vs-Female |
1.201030E-01 |
| Male-vs-Female |
1.195910E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.111200E-01 |
| Normal-vs-Extreme_Weight |
1.759590E-01 |
| Normal-vs-Obese |
7.068600E-01 |
| Normal-vs-Extreme_Obese |
3.579200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.404000E-01 |
| Normal_Weight-vs-Obese |
8.483200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.327000E-01 |
| Extreme_Weight-vs-Obese |
1.101590E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.552400E-01 |
| Obese-vs-Extreme_Obese |
2.225000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.703230E-03 |
| Normal-vs-Age(41-60Yrs) |
9.494400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.492200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.121400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.234410E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.371590E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.555200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.872400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.745800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.720800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.753200E-01 |
| Normal-VS-Type2 PRCC |
3.779200E-03 |
| Normal-VS-KIRP CIMP |
2.642100E-02 |
| Normal-VS-Unclassified PRCC |
7.523200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.41649999999494E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.257000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.657600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.375500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.292400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.044390E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.059370E-01 |
| Normal-vs-N1 |
1.789240E-01 |
| Normal-vs-N2 |
4.722200E-02 |
| N0-vs-N1 |
1.629820E-02 |
| N0-vs-N2 |
7.090000E-02 |
| N1-vs-N2 |
6.297600E-01 |
|
|
